ARDX Return on Tangible Equity | ARDELYX, INC.

ARDELYX, INC. (ARDX) Return on Tangible Equity

2026-06-30: Return Tang Equity -37.38%.
2026-03-31: Return Tang Equity -39.07%.
2025-12-31: Return Tang Equity -36.90%.
2025-09-30: Return Tang Equity -36.65%.

Complete source-backed return tang equity history.

Available history: 2012-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-37.38%
2026-03-31	-39.07%
2025-12-31	-36.90%
2025-09-30	-36.65%
2025-06-30	-40.41%
2025-03-31	-36.91%
2024-12-31	-22.58%
2024-09-30	-45.85%
2024-06-30	-44.32%
2024-03-31	-43.62%
2023-12-31	-39.60%
2023-09-30	-13.90%
2023-06-30	-45.54%
2023-03-31	-52.55%
2022-12-31	-68.35%
2022-09-30	-170.71%
2022-06-30	-254.19%
2022-03-31	-238.48%
2021-12-31	-191.44%
2021-09-30	-185.19%
2021-06-30	-106.60%
2021-03-31	-80.34%
2020-12-31	-74.79%
2020-09-30	-64.89%
2020-06-30	-61.95%
2020-03-31	-54.35%
2019-12-31	-50.86%
2019-09-30	-209.55%
2019-06-30	-150.98%
2019-03-31	-109.34%
2018-12-31	-78.83%
2018-09-30	-37.70%
2018-06-30	-30.55%
2018-03-31	-41.36%
2017-12-31	-46.18%
2017-09-30	-83.49%
2017-06-30	-78.66%
2017-03-31	-69.73%
2016-12-31	-58.19%
2016-09-30	-44.02%
2016-06-30	-62.02%
2016-03-31	-29.56%
2015-12-31	-27.20%
2015-09-30	-13.26%
2015-06-30	1.13%
2015-03-31	-6.29%
2014-12-31	-5.30%
2014-09-30	-5.55%
2014-06-30	-7.19%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-36.90%
2024-12-31	-22.58%
2023-12-31	-39.60%
2022-12-31	-68.35%
2021-12-31	-191.44%
2020-12-31	-74.79%
2019-12-31	-50.86%
2018-12-31	-78.83%
2017-12-31	-46.18%
2016-12-31	-58.19%
2015-12-31	-27.20%
2014-12-31	-5.30%
2013-12-31	10.34%
2012-12-31	17.05%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Avalo Therapeutics, Inc. (AVTX)	United States	$0.842B	-9.74
Immix Biopharma, Inc. (IMMX)	United States	$0.837B	-18.44
Cryoport, Inc. (CYRX)	United States	$0.881B	-21.29
Theravance Biopharma, Inc. (TBPH)		$0.885B	16.40
Obsidian Therapeutics, Inc. (OBX)	United States	$0.829B
LEXICON PHARMACEUTICALS, INC. (LXRX)	United States	$0.823B	-17.48
RIGEL PHARMACEUTICALS INC (RIGL)	United States	$0.893B	2.25
GYRE THERAPEUTICS, INC. (GYRE)	United States	$0.818B	-24.71
Apnimed, Inc. (APMD)	United States	$0.899B
GERON CORP (GERN)	United States	$0.803B	-12.14